SCHEMBL3841574

SCHEMBL3841574

O=C(O)NCCc1cc(-c2cccs2)c[nH]c1=O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
SMN1; SMN2 Q16637 6/20 0.43
HPGD P15428 4/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
KDM4E B2RXH2 4/20 0.43
KMT2A Q03164 2/20 0.43
LMNA P02545 2/20 0.43
MAPT P10636 1/20 0.43
PTPN1 P18031 1/20 0.41
GFER P55789 1/20 0.41
HIF1A Q16665 1/20 0.41
LTA4H P09960 2/20 0.37
PLA2G2A P14555 2/20 0.37
HTR1D P28221 1/20 0.37
HTR1B P28222 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846364 0.83 IDO1 (0.46) ALDH1A1SMN1; SMN2HPGDNPC1RAB9A
SCHEMBL3841735 0.81 PTPN1 (0.46) ALDH1A1NPC1KDM4EKMT2AMAPT
SCHEMBL3843553 0.72 ERCC1 (0.43) ALDH1A1SMN1; SMN2HPGDKDM4EKMT2A
SCHEMBL2731878 0.66 NPC1 (0.68) ALDH1A1SMN1; SMN2HPGDNPC1RAB9A
SCHEMBL4889367 0.65 EGLN1 (0.40) ALDH1A1RAB9ALMNAHDAC3HDAC1
SCHEMBL2027869 0.65 MCL1 (0.70) ALDH1A1SMN1; SMN2HPGDNPC1RAB9A
SCHEMBL10062922 0.63 ITK (0.67) ALDH1A1SMN1; SMN2RAB9AKDM4EKMT2A
SCHEMBL8054368 0.62 MTNR1A (0.75)
SCHEMBL12191001 0.62 RAB9A (0.56) ALDH1A1SMN1; SMN2HPGDNPC1RAB9A
SCHEMBL20792473 0.62 RAB9A (0.57) ALDH1A1SMN1; SMN2HPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114898-A2 NITROGEN-CONTAINING HETEROCYCLYL KETONES AND THEIR USE AS C-MET INHIBITORS Amgen Inc. (US) 2009-11-11 EP disclosed
WO-2008103277-A2 NITROGEN-CONTAINING HETEROCYCLYL KETONES AND THEIR USE AS C-MET INHIBITORS AMGEN INC. (US) 2008-08-28 WO disclosed